argenx to Report Full Year 2023 Financial Results and Fourth Quarter Business Update on February 29, 2024
February 22, 2024 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the […]
DMG Blockchain Solutions Reports First Quarter 2024 Results Ending December 31, 2023
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) — DMG Blockchain Solutions Inc. (TSX-V: DMGI) (OTCQB US: DMGGF) (FRANKFURT: 6AX) […]
Draganfly Announces Pricing of US$3.6 Million Underwritten Public Offering
Saskatoon, SK., Feb. 21, 2024 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), […]
TSX News -
Northland Power Reports Fourth Quarter 2023 Results and Announces 2024 Financial Outlook
Jacket for offshore sub-station – marking the first major piece of equipment heading to Taiwan (Hai Long) TORONTO, Feb. 21, […]
Teck Announces Base Dividend and Authorizes up to $500 Million Share Buyback
VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) announced […]
Proton Capital Enters Into Agreement to Purchase PharmaChoice Canada Branded Pharmacy In Saskatoon For Proposed Qualifying Transaction
REGINA, Saskatchewan, Feb. 21, 2024 (GLOBE NEWSWIRE) — PROTON CAPITAL CORP. (“Proton” or the “Corporation”) (PTN.P-TSX-V), is pleased to announce […]
XPENG announces dealer partnerships in UAE, Egypt, Azerbaijan, Jordan and Lebanon
XPENG, a leading Chinese smart electric vehicle company, announces dealer partnerships in UAE, Egypt, Azerbaijan, Jordan and Lebanon. Through the […]
Symbotic Announces Pricing of Primary and Secondary Offering of Class A Common Stock
WILMINGTON, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) — Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the […]
Carriage Services Announces Fourth Quarter and Full Year 2023 Results
HOUSTON, Feb. 21, 2024 (GLOBE NEWSWIRE) — Carriage Services, Inc. (NYSE: CSV) today announced results for the fourth quarter and […]
TSX News -
Knight Therapeutics Announces Regulatory Submission of Fostamatinib in Brazil
MONTREAL, Feb. 21, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced […]
